Patient Perspectives in Mantle Cell Lymphoma Clinical Research
- Trial number:
- NCT06049472
- Trial phase:
- N/A
- Study type:
- Any
- Overall status:
- Recruiting
Study start date
October, 2024
Scientific title
Exploring Patient Engagement Patterns and Participation Trends in Mantle Cell Lymphoma Clinical Trials
Summary
Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization.
This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.
Confirmed diagnosis of mantle cell lymphomaNo serious medical or psychiatric illness likely to interfere with participation in this clinical study. Ability to understand and the willingness to sign a written informed consent document.
Study design
Time perspective:
Prospective, Observational model:
Case-Crossover,
Conditions
Mantle Cell Lymphoma
Other study ID numbers
70247036